established accreditation standards for hospital pharmacy residencies in 1962, a general guideline was that the pharmacy department should be adequately staffed without the residents. At that time, most pharmacists in the leading hospital pharmacies were dispensing medications and supervising activities such as prepackaging, bulk manufacturing and drug purchasing. The important exceptions were the chief pharmacist and the assistant director. If residency programs were going to train future leaders in hospital pharmacy, the ASHP realized that the main thrust of the residency should not be in these rather technical areas. Residents in the better programs spent much of their time with special projects and administrative matters. The role model residents tried to emulate was that of the director of pharmacy, not that of the staff pharmacist.
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Perhaps it is useful to compare pharmacy with the medical model of residency training. The resident in surgery, pediatrics, internal medicine, psychiatry or obstetrics is very clearly being trained to be a surgeon, pediatrician, internist, psychiatrist or obstetrician. The emphasis in the residency is not upon becoming a department head or medical administrator. Only a small minority of the residents will follow this path, and then only after years of practice, research and teaching. Most of the residents will not go on into research and medical school teaching, but will go into practice. The residents emulate the practitioners around them, and hope that after years of experience they will be as proficient and wise.
One of the shortcomings in pharmacy practice has been the lack of substance in the professional career of the average pharmacist. The ASHP exerted considerable wisdom in not allowing an accredited residency to degenerate into largely a staff pharmacist type of practice. While this wisdom was needed in the past, it is time for a new wisdom. Just as the fruit tree that bears no fruit is cut down, those in the profession that bear no fruit should be cast out. The barren tree requires sun, rain, and nutrients just as the healthy tree, and its presence takes away from the resources available to the tree bearing fruit. Even if it means fewer pharmacists in certain hospitals, the practice of the staff pharmacist needs to be elevated so that the resident in training has more than the director of pharmacy to emulate.
If pharmacy practice is developed as it should be, the resident should primarily be in training to leam to practice as the staff of a hospital practices. The two main areas in which pharmacists practice should be high level administration and management and clinical pharmacy. Within the areas of clinical pharmacy, there should be several specialties, particularly in the university teaching hospital. Only when the practice of all the staff is at a high level can the dichotomy between the purpose of a residency and the practice of the staff be eliminated. The accomplishment of this level of pharmacy practice is a prerequisite for the emancipation of the profession and the development of strong residencies based on realistic role models. When this elevation occurs, there need be no stipulation that the resident must be nonessential to the operation of the department of pharmacy.
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The Fatal Drug Reaction Debate DRUG INDUCED DISEASES are responsible for an unfortunately large number of hospitalizations in this country and abroad. Studies in the United States, Ireland, Australia and New Zealand have almost uniformly shown that about five percent of patient admissions to hospital general medical services are attributable to drug induced illness. Furthermore, 10 to 30 percent of all patients admitted to medical wards will acquire an adverse drug reaction during their stay and the fatality rate of these reactions generally ranges from 3 to 13 percsnt, averaging 5 percent. Unfortunately, extrapolations based on these statistics were made suggesting that approximately 1.5 million hospitalizations result annually at an estimated cost of 3 billion dollars and that some 50,000 deaths occur annually as a result of adverse drug reactions.
These estimates have caused many scientists to take to their pens and soapboxes. Considerable debate has ensued in the recent medical and pharmaceutical literature concerning the exact number of patients dying from adverse drug reactions. Numerous editorial comments have appeared in the form of professional journals, newsletters, newspapers and even television. Those who believe that drugs are safe have criticized the studies contending that they were largely university based, therefore not representative, and included many reactions that occurred in terminally ill patients. They argue that the fatality rate is much less, probably 30,000 deaths annually. On the other hand, those who maintain drugs are hazardous concluded that the studies did not detect all reactions, they were not conducted in outpatient populations where the majority of drug therapy occurs and furthermore they were conducted in university settings.
